Effect of Lifitegrast 5% on Tear Film Markers

NCT03952481 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped COVID restrictions

Conditions

Dry Eye
Dry Eye Syndromes
Dry Eyes Chronic

Interventions

DRUG: Lifitegrast 5% Ophthalmic Solution

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]